These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28927945)

  • 1. Consensus Approaches to Identify Incident Dementia in Cohort Studies: Systematic Review and Approach in the Successful Aging after Elective Surgery Study.
    Kimchi EY; Hshieh TT; Guo R; Wong B; O'Connor M; Marcantonio ER; Metzger ED; Strauss J; Arnold SE; Inouye SK; Fong TG
    J Am Med Dir Assoc; 2017 Dec; 18(12):1010-1018.e1. PubMed ID: 28927945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    Yuan J; Maserejian N; Liu Y; Devine S; Gillis C; Massaro J; Au R
    J Alzheimers Dis; 2021; 79(2):807-817. PubMed ID: 33361590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.
    Atti AR; Valente S; Iodice A; Caramella I; Ferrari B; Albert U; Mandelli L; De Ronchi D
    Am J Geriatr Psychiatry; 2019 Jun; 27(6):625-637. PubMed ID: 30917904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum.
    Townley RA; Syrjanen JA; Botha H; Kremers WK; Aakre JA; Fields JA; Machulda MM; Graff-Radford J; Savica R; Jones DT; Knopman DS; Petersen RC; Boeve BF
    Mayo Clin Proc; 2019 Aug; 94(8):1516-1523. PubMed ID: 31280871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.
    Brodaty H; Heffernan M; Kochan NA; Draper B; Trollor JN; Reppermund S; Slavin MJ; Sachdev PS
    Alzheimers Dement; 2013 May; 9(3):310-317.e1. PubMed ID: 23110866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
    Solfrizzi V; Scafato E; Capurso C; D'Introno A; Colacicco AM; Frisardi V; Vendemiale G; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Capurso A; Panza F;
    Neurobiol Aging; 2011 Nov; 32(11):1932-41. PubMed ID: 20045217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Aversion and Alzheimer Disease in Old Age.
    Wilson RS; Yu L; Schneider JA; Bennett DA; Boyle PA
    Am J Geriatr Psychiatry; 2019 Aug; 27(8):851-861. PubMed ID: 30982702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.
    Sachdev PS; Lipnicki DM; Crawford J; Reppermund S; Kochan NA; Trollor JN; Draper B; Slavin MJ; Kang K; Lux O; Mather KA; Brodaty H;
    J Am Geriatr Soc; 2012 Jan; 60(1):24-33. PubMed ID: 22142389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan.
    Sun Y; Lee HJ; Yang SC; Chen TF; Lin KN; Lin CC; Wang PN; Tang LY; Chiu MJ
    PLoS One; 2014; 9(6):e100303. PubMed ID: 24940604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
    Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
    JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD and the risk of mild cognitive impairment and dementia: a cohort study based on the Chinese Longitudinal Health Longevity Survey.
    Xie F; Xie L
    Int J Chron Obstruct Pulmon Dis; 2019; 14():403-408. PubMed ID: 30863040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    Myung W; Lee C; Park JH; Woo SY; Kim S; Kim S; Chung JW; Kang HS; Lim SW; Choi J; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim SY; Carroll BJ; Kim DK
    J Alzheimers Dis; 2017; 55(1):283-292. PubMed ID: 27662289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Validation and Field Evaluation of the Singapore Longitudinal Ageing Study (SLAS) Risk Index for Prediction of Mild Cognitive Impairment and Dementia.
    Ng TP; Lee TS; Lim WS; Chong MS; Yap P; Cheong CY; Yap KB; Rawtaer I; Liew TM; Gao Q; Gwee X; Ng MPE; Nicholas SO; Wee SL
    J Prev Alzheimers Dis; 2021; 8(3):335-344. PubMed ID: 34101792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
    Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.